AMA

Valencia Technologies Corporation announced today that the Department of Health and Human Services, Centers for Medicare & Medicaid Services (CMS), published the 2024 Medicare Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment

Retrieved on: 
Tuesday, November 7, 2023
Patient, FDA, ASC, Health, Ambulatory Surgery Center Association, Medicare, OAB, The Final Rule, PMA, United, AMA, Addendum, Quality of life, Leg, APC, Physician, Safety, CPT, Outpatient surgery, Hospital, Urinary incontinence, CMS

VALENCIA, Calif., Nov. 7, 2023 /PRNewswire/ -- As outlined in the 2024 Medicare Program: HOPPS and ASC Payment Systems Final Rule, CMS has confirmed that new Category III CPT code 0816T for reporting the eCoin system implantable tibial nerve stimulation procedure across all service locations has been assigned to Medicare Hospital Outpatient Prospective Payment System Ambulatory Payment Classification (APC) 5464 beginning CY'24. In the hospital outpatient site of service, APC 5464 has been assigned a Medicare unadjusted, national average payment rate of US$20,865, as referenced in Addendums A and B of the Final Rule. 

Key Points: 
  • Furthermore, CPT code 0816T describing the eCoin system procedure has been categorized as device-intensive by CMS.
  • This categorization ensures a more comprehensive Medicare payment in the Ambulatory Surgery Center (ASC) in comparison to procedures not deemed device-intensive.
  • Ann Decker, VP of Reimbursement for Valencia Technologies, commented, "The payment Rules for Hospital outpatient (HOPPS) and Ambulatory Surgery Center (ASC) by CMS are a testament to the constructive discussions between Valencia Technologies and CMS.
  • Patients are encouraged to visit Valencia's patient website at www.eCoin.us for more information about this novel therapy for UUI.

Yamaha Celebrates Outstanding 2023 Off-Road Racing Season with Multiple Championships

Retrieved on: 
Wednesday, November 1, 2023
Shift, Grand National Cross Country, Cru, Social media, Ford, 2010 AMA Pro American Superbike Championship, WXC, UTV, Name Your Adventure, GNCC, Motos, Quadcross of Nations, ATV, AMA, Pro stock, Blu, Breast cancer, Proven, Montgomery County, Circuit Gilles Villeneuve, United States national team, Catmose College, Plaque, Research, Jos Wienen, School, Series, Hammer, Susan G. Komen for the Cure, Cure, SBC, YXZ, SxS, DASA, Student, XC2, Collection, Phoenix, Tissue paper, Television, Yamaha

MARIETTA, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Yamaha Motor Corp., USA , proudly marks the culmination of a remarkable 2023 off-road racing season, characterized by an outstanding collection of championship victories and significant philanthropic endeavors.

Key Points: 
  • MARIETTA, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Yamaha Motor Corp., USA , proudly marks the culmination of a remarkable 2023 off-road racing season, characterized by an outstanding collection of championship victories and significant philanthropic endeavors.
  • Anderson's remarkable feat was celebrated with a $5,000 bLU cRU bonus for being the top-placing Yamaha Side-by-Side (SxS) at KOH.
  • Another Yamaha podium sweep took place at the Yamaha Racing Ironman finale of the Grand National Cross Country (GNCC) series in Crawfordsville, Indiana.
  • Additional charity endeavors at the Yamaha Racing Ironman GNCC included Yamaha bLU cRU racers, comprised of the Walker Fowler Racing and AmPro Yamaha teams, building balance bikes the Friday before race day.

Curonix Celebrates 1st Anniversary

Retrieved on: 
Wednesday, November 1, 2023
SCS, Education, Jessika Carr, PNS, Freedom, Physician, American Medical Association, AMA, Society, HF, Safety, Patient, Nursing, Pharmaceutical industry

POMPANO BEACH, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Today, Curonix LLC, a leading peripheral nerve stimulation company celebrated its first anniversary.

Key Points: 
  • POMPANO BEACH, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Today, Curonix LLC, a leading peripheral nerve stimulation company celebrated its first anniversary.
  • In November 2022, Curonix completed the purchase of substantially all assets, excluding liabilities, of Stimwave Technologies.
  • “Curonix is a new company that was formed to deliver much-needed non-opioid chronic pain relief with our innovative HF-EMC technology platform.
  • “We are excited to support Curonix as it serves patients and physicians,” said David Kho, Curonix Chairman of the Board, and Managing Director at Kennedy Lewis.

HistoSonics Notches Significant Reimbursement Wins

Retrieved on: 
Monday, November 6, 2023
Radiology, Research, Insurance, Oncology, Software, Medical Devices, Hardware, Hospitals, Professional Services, Science, Technology, Clinical Trials, FDA, Biotechnology, Surgery, Health, Health Technology, Health Insurance, Liver, Sale, Medicare, Government, Diagnosis-related group, Physician, High-intensity focused ultrasound, American Medical Association, Infection, Kidney, Bleeding, Blue, Ambulatory Payment Classification, Multimedia, IDE, AMA, Tissue, APC, Diagnosis, Hospital, Centers for Medicare & Medicaid Services, CPT, Pain, Patient, Investigational New Drug, DRG, CMS, Medical imaging, Medicaid

We commend CMS on facilitating access to breakthrough devices like ours for Medicare patients, many of whom historically have had delayed access to innovative technology,” commented HistoSonics President and CEO Mike Blue.

Key Points: 
  • We commend CMS on facilitating access to breakthrough devices like ours for Medicare patients, many of whom historically have had delayed access to innovative technology,” commented HistoSonics President and CEO Mike Blue.
  • HistoSonics’ Edison Histotripsy System combines advanced imaging and proprietary software to deliver patient specific treatments and uses the science of histotripsy to mechanically destroy targeted tissues at sub-cellular levels.
  • Additionally, the American Medical Association (AMA) has recently issued a new Category III CPT code for histotripsy of kidney tissue.
  • The release of this new code represents a major reimbursement milestone as hospitals across the US will be able to submit claims directly related to the service.

Global Super Star and Entrepreneur Chris Brown Takes Delivery of his FF 91 2.0 Vehicle After Completing a Month of Co-Creation Sharing for the Company

Retrieved on: 
Monday, November 6, 2023
Technology, Entertainment, Automotive Manufacturing, EV, Electric Vehicles, Manufacturing, Apps, Applications, Alternative Vehicles, Fuels, Automotive, Celebrity, Environment, IOT (Internet of Things), Software, Internet, Green Technology, Jia Yueting, Co-creation, Music, Multimedia, AMA, MTV Europe Music Awards, 2008 MTV Video Music Awards, Faraday Future, FF, Grammy Awards

Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced that global superstar and entrepreneur Chris Brown has taken delivery of his FF 91 2.0 Futurist Alliance, after spending a month of Co-Creation efforts involving his testing and driving of a FF 91 2.0 Futurist Alliance.

Key Points: 
  • Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced that global superstar and entrepreneur Chris Brown has taken delivery of his FF 91 2.0 Futurist Alliance, after spending a month of Co-Creation efforts involving his testing and driving of a FF 91 2.0 Futurist Alliance.
  • Mr. Brown has now officially become an owner and Developer Co-Creation Officer for FF.
  • The Company received valuable feedback from Mr. Brown, and this feedback not only enhanced his personal FF 91 2.0 but is also expected to enhance the Company’s overall user experience and further highlights the advantages of the Company’s Developer Co-Creation program.
  • “The FF 91 2.0 is the pinnacle of luxury, technology and performance, and we are excited to see that Mr. Brown’s interest in our brand and vehicle exemplifies the same passion for our vehicle that we have,” said Matthias Aydt, Global CEO of FF.

Aerin Medical Announces Advances for Chronic Rhinitis Treatment with New CPT® Code and Final CMS-Established Payment Rates

Retrieved on: 
Friday, November 3, 2023
Medical Supplies, Health, Medical Devices, Health Technology, Other Health, Other Science, Science, PNN, ENT, Education, Medicare, Aerin Lauder, Ear, Physician, American Medical Association, Nose, Rhinorrhea, MBA, Radiofrequency ablation, AMA, Multimedia, Congestion, Partnership, Center for Medicare and Medicaid Innovation, Allergy, CPT, Patient, Centers for Medicare & Medicaid Services, CMS, Thomas Jefferson University, Hospital, Nursing, Health insurance

The new code describes the procedure performed by ENT physicians when treating overactive nerves that drive chronic rhinitis symptoms with Aerin Medical’s RhinAer®.

Key Points: 
  • The new code describes the procedure performed by ENT physicians when treating overactive nerves that drive chronic rhinitis symptoms with Aerin Medical’s RhinAer®.
  • View the full release here: https://www.businesswire.com/news/home/20231031993246/en/
    CMS is set to implement a new CPT code that improves access to chronic rhinitis treatment with RhinAer® for patients often stuck in an unproductive cycle of care.
  • RhinAer is supported by a strong body of clinical evidence demonstrating significant, durable symptom improvement for chronic rhinitis patients.
  • Treatment with RhinAer is non-invasive and can be performed by ENT physicians in the office and outpatient surgical settings.

'Listen to your patients for early identification of Peripheral Neuropathy' say leading Health Experts at P&G's #KNOWTHESIGNS Scientific Forum

Retrieved on: 
Monday, November 6, 2023
Global Medical Device Nomenclature, Patient, Ulcer, Education, PN, Prickle (protein), Neuropathic pain, Neurology, Assistant, Facial muscles, Physician, Prevalence, IDF, Burning Sensations, Health, International Diabetes Federation, DPN, Type 2 diabetes, WDD, Finger, Foot, Hypoesthesia, Senior, AMA, Prediabetes, Paresthesia, Quality of life, Bethesda Hospital, The, Extremities, Risk, P&G, Peripheral neuropathy, Lyceum, Trial of the century, B, Pharmacist, Ankle, Amputation, Diagnosis, Consultant, Infection, Dietary supplement, Pharmaceutical industry, Diabetes

The signature event saw deliberations on the latest clinical guidance on diagnoses and treatment of Peripheral Neuropathy (PN) in Diabetes and Pre-Diabetes.

Key Points: 
  • The signature event saw deliberations on the latest clinical guidance on diagnoses and treatment of Peripheral Neuropathy (PN) in Diabetes and Pre-Diabetes.
  • With Diabetes Mellitus Type 2 being the leading cause of PN, its increasing prevalence is closely linked to the rise in the number of diabetics.
  • B vitamin deficiency and polymedication are other high-risk factors along with diabetes, leading to peripheral nerve damage.
  • Patients should be educated about the importance of regular foot and DPN examinations, glycemic control, and adherence to prescribed medications.

The Inner Circle Acknowledges, Timothy Kruse as a Most Trusted Business Professional for his contributions to the field of Accounting

Retrieved on: 
Friday, November 3, 2023
Patient, Stroke, Medical school, University of Colorado School of Medicine, Health, Health care, AAFP, Family therapy, MD, Carleton College, Master, AMA, Medical degree, House, Inner circle, School, American Academy, University, Woman, American Academy of Family Physicians, Memory, Nursing, Family medicine, Biology, Medicine, Marriage

BASALT, Colo., Nov. 3, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Timothy Kruse is acknowledged as a Healthcare Professional for his contributions to the field of Family Medicine.

Key Points: 
  • BASALT, Colo., Nov. 3, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Timothy Kruse is acknowledged as a Healthcare Professional for his contributions to the field of Family Medicine.
  • He completed a Medical Degree from the University of Colorado, School of Medicine in 1996; completed a residency in family medicine at St. Joseph Family Practice Hospital in Denver.
  • Dr. Kruse is a trusted family physician with Premier Medical Center pioneering a new personalized approach to medical care in Basalt Colorado.
  • Dr. Kruse would like to dedicate this honor in memory of his mentor, Dr. Thomas, MD and thank his father, Mr. Richard Kruse, for all his support.

INSIGHTEC ANNOUNCES NEW CATEGORY I CPT® CODE FROM AMA FOR NEURO PROCEDURES USING MR-GUIDED FOCUSED ULTRASOUND

Retrieved on: 
Thursday, November 2, 2023
FDA, Cat, Essential tremor, Tremor, Parkinson's disease, American Association of Neurological Surgeons, Neuro, Physician, American Medical Association, Congress, MD, CNS, Health, High-intensity focused ultrasound, AMA, AANS, Congress of Neurological Surgeons, DSM-IV codes, Patient, Medical imaging, Medical device, Insightec

HAIFA, Israel and MIAMI, Nov. 2, 2023 /PRNewswire/ -- Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced that the editorial panel of the American Medical Association (AMA) approved their application to establish a new Category (Cat) I Current Procedural Terminology (CPT®) code to facilitate reimbursement for MR-guided focused ultrasound (MRgFUS) ablation of neurological targets. The Cat I CPT® code will be included in the next CPT® codebook and expected to be effective January 1, 2025.

Key Points: 
  • The Cat I CPT® code will be included in the next CPT® codebook and expected to be effective January 1, 2025.
  • "We've long known that focused ultrasound has a significant and valuable role in treating patients with neurological disorders.
  • "This approval can also lead to expanded access to focused ultrasound for US patients," says Dee Kolanek, vice president of market access and reimbursement for Insightec.
  • Focused ultrasound, which was pioneered by Insightec, is FDA approved to treat essential tremor and Parkinsonian tremor.

QuantalX Secures Dedicated Reimbursement Code for Delphi-MD Test, Advancing Improved Brain Health

Retrieved on: 
Thursday, November 2, 2023
Stroke, FDA, MRI, Medicare, Neurology, American Medical Association, Physician, Breakthrough, Doctor of Philosophy, Health, Dementia, AMA, DSM-IV codes, Caregiver, Myenteric plexus, NPH, Risk, CT, Brain, CPT, Patient, VPS, Pharmaceutical industry, Medical imaging

NEW YORK, Nov. 2, 2023 /PRNewswire/ -- QuantalX Neuroscience, a pioneering healthcare company dedicated to early detection of brain disorders, is pleased to announce that it has secured a US reimbursement code, 0858T, from the American Medical Association (AMA). This milestone achievement is a significant part of the company's pre-commercialization strategy in the US.

Key Points: 
  • QuantalX announces the authorization of a dedicated US reimbursement code for its point-of-care brain health test by the American Medical Association (AMA).
  • NEW YORK, Nov. 2, 2023 /PRNewswire/ -- QuantalX Neuroscience , a pioneering healthcare company dedicated to early detection of brain disorders, is pleased to announce that it has secured a US reimbursement code, 0858T, from the American Medical Association (AMA).
  • The newly assigned CPT code signifies Delphi-MD's importance in early brain health assessment, catering to brain health evaluation procedures at any clinical setting using a collaborative care model.
  • The Delphi-MD technology is  a first-in-class automated, Direct Neuro-Physiological technology to detect and assess brain abnormalities, as well as predict treatment response.